`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`RANBAXY INC. and SUN PHARMACEUTICAL INDUSTRIES, LTD.,
`Petitioners
`
`v.
`
`ADAMAS PHARMACEUTICALS, INC.,
`Patent Owner
`
`
`
`
`Inter Partes Review No.: 2015-00410
`
`U.S. Patent No. 8,362,085
`
`
`
`
`
`
`
`Petitioners’ Mandatory Notices – Updated Real Parties-in-Interest
`37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`Petitioners Ranbaxy Inc. and Ranbaxy Laboratories Ltd. (n/k/a Sun
`
`Pharmaceutical Industries, Ltd.) (“Petitioners”) hereby provide notice of revised real
`
`parties-in-interest in this proceeding. These revised mandatory notices reflect that
`
`effective March 24, 2015, Petitioner Ranbaxy Laboratories, Ltd. merged with Sun
`
`Pharmaceutical Industries, Ltd. Sun Pharmaceutical Industries, Ltd. is the sole
`
`surviving entity of that merger and thus is a Petitioner in this proceeding. Pursuant to
`
`37 C.F.R. § 42.8(a)(3), Petitioners’ updated mandatory notices are below, reflecting
`
`these amendments.
`
`I. MANDATORY NOTICES (37 C.F.R. § 42.8)
`A. Real Party-In-Interest (37 C.F.R. § 42.8(b)(1))
`Ranbaxy Inc. and Sun Pharmaceutical Industries, Ltd are the real parties-in-
`
`interest for Petitioners.
`
`Ranbaxy Inc. is not a publicly traded corporation, and is a wholly owned
`
`subsidiary of Ranbaxy Holdings (U.K.) Ltd., which is a wholly owned subsidiary of
`
`Ranbaxy (Netherlands) B.V., which in turn is wholly owned by Sun Pharmaceutical
`
`Industries, Ltd. Sun Pharmaceutical Industries, Ltd. is the only publicly traded parent
`
`company of Ranbaxy, Inc. Sun Pharmaceutical Industries, Ltd. is a publicly traded
`
`corporation, and no parent company or publicly traded corporation owns 10% or
`
`more of Sun Pharmaceutical Industries, Ltd.’s stock.
`
`
`
`2
`
`
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2))
`Petitioners are not aware of any reexamination certificates or pending
`
`prosecution concerning the ’085 patent. Petitioners are parties to a pending litigation
`
`regarding infringement and invalidity of the ’085 patent, namely Forest Laboratories,
`
`Inc. et al v. Ranbaxy Inc. et. al, Civ. Action No. 14-cv-686, currently pending in the
`
`District of Delaware. There are also pending litigations regarding infringement and
`
`invalidity of the ’085 patent currently pending against additional parties in the District
`
`of Delaware, including Civ. Action Nos. 14-cv-121, 14-cv-200, 14-cv-508, 14-cv-
`
`1058, and 14-cv-1271.
`
`There are also two pending applications claiming benefit to the ’085 patent,
`
`namely No. 14/081,643, filed on November 15, 2013, and No. 14/339,599, filed on
`
`July 24, 2014.
`
`C.
`
`Identification of Counsel (37 C.F.R. § 42.8(b)(3))
`
`Lead Counsel
`John W. Bateman
` (Reg. No. 41,602)
`KENYON & KENYON LLP
`1500 K Street, NW
`Washington, DC 20005
`jbateman@kenyon.com
`Tel: 202.220.4216
`Fax: 202.220.4201
`
`
`Back-up Counsel
`Karen C. Shen
` (Reg. No. 60,412)
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`kshen@kenyon.com
`Tel: 212.908.6206
`Fax: 212.425.5288
`
`D.
`Service Information (37 C.F.R. § 42.8(b)(4))
`Please direct all correspondence to lead counsel and back-up counsel at the
`3
`
`
`
`
`
`contact information above. Petitioners consent to service by electronic mail at
`
`jbateman@kenyon.com and kshen@kenyon.com.
`
`
`
`
`Dated: April 8, 2015
`
`
`
`
`
`John W. Bateman
` (Reg. No. 41,602)
`KENYON & KENYON LLP
`1500 K Street, NW
`Washington, DC 20005
`jbateman@kenyon.com
`Tel: 202.220.4216
`Fax: 202.220.4201
`
`
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby confirms that the foregoing Petitioners’ Mandatory
`
`Notices – Updated Real Parties-in-Interest was served on April 8, 2015 via e-email upon the
`following counsel of record for the Patent Owner.
`
`
`
`Peter J. Armenio, P.C.
`QUINN EMMANUEL URQUHART & SULLIVAN, LLP
`51 Madison Avenue
`22nd Floor
`New York, NY 10010
`
`
`Evangeline L. Shih
`QUINN EMMANUEL URQUHART & SULLIVAN, LLP
`51 Madison Avenue
`22nd Floor
`New York, NY 10010
`
`
`
`
`Dated: April 8, 2015
`
`
`
`
`
`Hannah Rose Stein
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`hstein@kenyon.com
`Tel: 212.908.6398
`Fax: 212.425.5288
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
